维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="NOSKIN GA"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci:position statement from the Joint SHEA and APIC Task Force显示文摘	Weber SG Huang SS Oriola S W.Huskins C Noskin GA Harriman K		American Journal of Infection Control0，，：	1
2	New technology for detecting mul- tidrug-resistantpathogens in the clinical microbiology laborato- ry显示文摘	Peterson LR Noskin GA	2001	Eme-rg Infect Dis2001，7，2：	1
3	In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci 显示文摘	Noskin GA Siddiqui F Stosor V et ai	1999	Antimicrob Agents Chemother1999，43，8：	1
4	Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram- positive infections in cancer patients with neutropenia 显示文摘	Smith PF Birmingham MC Noskin GA	2003	Ann Oncol2003，14，5：	1
5	In vitro activities of linezolid agaist important gram-positive bacterial pathogens including vancomycin-resistant enterococci显示文摘	Noskin GA Siddiqul F Stosor V	1999	Antimicrob Agents Chemother1999，43，：	1
6	Successful treatment of persistent bactericidal due to vancomycin-resistant, ampicillin-resistant Enterococcus显示文摘	Mekonen ET Noskin GA Hacek DM	1995	Microb Drug Resist1995，1，3：	1
7	In vitro acti-vities of linezolid againstimportant Gram-positive ba-cterial pathogens including vancomycin-resistantent-erococci显示文摘	Noskin GA Siddiqui F Stosor V	1999	Antimicrob Agents Chemother1999，43，：	1
8	National trends in Staphylococcus anreus infection rates: impact on economic burden and mortality over a 6 - year period ( 1998 - 2003 ) 显示文摘	Noskin GA Rubin R J Schentag JJ	2007	Clin Infect Dis2007，45，9：	1
9	Successful treat-ment of persistantvancomycin-resistant enterococcus faecium bactermia with linezolid and gentamicin显示文摘	Noskin GA Siddiqui F Stosor V	1999	Cl-in Infect Dis1999，，：	1
10	A randomized, openlabel, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with he matologic malignancies 显示文摘	Bow EJ Rotstein C Noskin GA	2006	Clin Infect Dis2006，43，：	1
11	Recovery of vancomy cin-resistant enterococci on fingertips and environmental surfaces显示文摘	Noskin GA Stosor V Cooper I etal	1995	Infect Control Hosp Epidemiol1995，16，：	1
12	Antibiotic considerations in the treatment of multidrug-resistant(MDR)pathogens:a case-based review显示文摘	Reddy P Chadaga S Noskin GA	2009	J Hosp Med2009，4，6：	1
13	Vancomycin resistant Enterococci :clinical, microbiologic, and epidemiologic features 显示文摘	Noskin GA	1997	J Lab Clin Med1997，130，1：	1
14	Safety,efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia显示文摘	Smith PF Birmingham MC Noskin GA	2003	Ann Oncol2003，14，5：	1
15	Intracellulartargets of moxifloxacin: a comparison with otherfluoroquinolones 显示文摘	Pestova E Millichap JJ Noskin GA	2000	J Antimicrob Chemoth2000，45，5：	1
16	Antibiotic considera- tions in the treatment of multidrug-resistant (MDR) patbogens:a case-based review显示文摘	Reddy P Chadaga S Noskin GA	2009	J Hosp Med2009，4，6：	1
17	Persistent methicillin-re- sistant staphylococcus aureus bacteremia due to a prostatic abscess显示文摘	Fraser TG Smith ND Noskin GA	2003	Scand J Infect Dis2003，35，4：	1
18	Tigecycline : a new glycylcycline for treatment ofserious infections显示文摘	Noskin GA	2005	Clin Infect Dis2005，41，5：	1
19	Bacterial pneumonia associated with HIV-1 infection显示文摘	Noskin GA Glassroth J	1996	Clin Chest Med1996，17，4：	1
20	Antibiotic considerations in the treatment of multidrug resistant(MDR) pathogens: a case based review显示文摘	Reddy P Chadaga S Noskin GA	2009	J Hosp Med2009，4，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示